Aortic
Introduction
The aorta is the body's largest artery, originating from the heart's left ventricle and extending through the chest and abdomen. Its critical role is to deliver oxygenated blood to all systemic circulation. The structural integrity and functional health of the aorta are fundamental to cardiovascular well-being. Variations in aortic characteristics, such as its dimensions or the presence of calcification, serve as significant indicators of cardiovascular disease risk.
Biological Basis
Genetic factors play a substantial role in determining various aortic characteristics. Research, including genome-wide association studies (GWAS), has explored the heritability and genetic architecture underlying aortic traits. For example, the heritability of aortic root dimension has been estimated at 52% [1] highlighting a strong genetic influence. These studies have identified specific genetic variants associated with echocardiographic dimensions, including aortic root diameter. [1] Additionally, abdominal aortic calcification (AAC), a key marker of subclinical atherosclerosis, has been a focus of genetic association analyses [2] revealing genetic links to this condition. Such investigations enhance our understanding of the complex interplay between an individual's genetic makeup and aortic health.
Clinical Relevance
Aortic traits hold significant clinical relevance as they are vital indicators for assessing cardiovascular health and disease progression. An enlarged aortic root can be indicative of conditions like aortic aneurysm, while the presence of calcification within the aorta is a hallmark of atherosclerosis. Subclinical atherosclerosis, particularly abdominal aortic calcification, has been demonstrated to predict future cardiovascular disease risks independently of traditional risk factors. [2] The identification of genetic associations with these traits can facilitate early risk stratification, enabling tailored interventions and personalized medicine strategies to prevent severe cardiovascular events.
Social Importance
Cardiovascular diseases, which include conditions affecting the aorta, represent a leading cause of morbidity and mortality globally, thus imposing a considerable public health burden. A deeper understanding of genetic predispositions to aortic abnormalities can lead to the development of improved screening methods and more effective preventive strategies. By identifying individuals at a higher genetic risk, healthcare providers can implement earlier lifestyle modifications, pharmacotherapy, or enhanced monitoring protocols, potentially reducing the incidence and severity of aortic-related complications. This genetic insight offers promising avenues for improving public health outcomes and enhancing the quality of life for many individuals.
Methodological and Statistical Constraints
The interpretability of genetic associations for aortic traits is subject to several methodological and statistical limitations. The study utilized the Affymetrix 100K GeneChip, which offered partial coverage of genetic variation, thereby limiting the ability to detect all potentially relevant genetic effects and to replicate prior findings comprehensively. [1] Furthermore, while the study had over 90% power to detect associations explaining 4% or more of phenotypic variation at a stringent alpha level, the overall findings did not meet the conservative genome-wide significance threshold of 5x10^-8 after Bonferroni correction, suggesting that some of the reported associations may represent false positives despite being biologically plausible candidates. [2] The choice of an 80% genotyping call rate threshold, while increasing inclusivity, may also have introduced additional noise into the analysis. [1]
Validation of these findings necessitates replication in independent cohorts, as the exploratory nature of some analyses, particularly those focusing on selected candidate genes, underscores the need for external confirmation. [3] Without such replication, the generalizability and robustness of the observed associations remain to be fully established, impacting the confidence with which these genetic variants can be considered definitive contributors to aortic phenotypes.
Phenotype Assessment and Population Specificity
The characterization of echocardiographic traits, including aortic root dimension, involved averaging measurements across up to four examinations spanning a period of twenty years. [1] While intended to reduce regression dilution bias, this approach may introduce misclassification due to evolving echocardiographic equipment over two decades. Moreover, such long-term averaging implicitly assumes that the same genetic and environmental factors influence traits consistently across a wide age range, potentially masking age-dependent gene effects that could be crucial for understanding the dynamic genetic architecture of aortic traits. [1]
A significant limitation concerning generalizability is the study's exclusive focus on a cohort of white individuals of European descent. [1] The genetic architecture and environmental interactions influencing aortic phenotypes can vary considerably across different ancestral populations. Therefore, the applicability of these findings to other ethnicities remains unknown, highlighting the need for future research in diverse populations to ascertain the broader relevance of the identified genetic associations.
Unexplored Gene-Environment Interactions and Heritability Gaps
The current research did not investigate gene-environment interactions, which are known to modulate genetic influences on complex traits. [1] For instance, associations of ACE and AGTR2 with left ventricular mass have been shown to vary with dietary salt intake, indicating that environmental factors can significantly alter the phenotypic expression of genetic variants. [1] The absence of such analyses means that potential context-specific genetic effects on aortic traits remain uncharacterized, limiting a comprehensive understanding of their etiology.
Despite identifying genetic associations, a substantial portion of the heritability for traits like aortic root dimension (52%) and left ventricular mass (36–40%) remains unexplained by the current findings. [1] This "missing heritability" points to existing knowledge gaps regarding the full spectrum of genetic variants, including rarer alleles or complex epistatic interactions, that contribute to the inter-individual variability in aortic phenotypes. Further research is warranted to uncover these unaddressed genetic components and their interplay with environmental factors.
Variants
Genetic variations play a crucial role in influencing the structure and function of the aorta, with numerous genes contributing to its elasticity, remodeling, and susceptibility to disease. Variants in or near genes such as ELN, CAST, HDAC9, TWIST1, PLCE1, and MAP2K4 are of particular interest due to their established biological roles in vascular biology. These genes, along with various long non-coding RNAs (lncRNAs) and pseudogenes, can modulate pathways that impact aortic health, potentially leading to conditions such as aortic root dilation or calcification. Understanding these genetic influences is key to unraveling the complex etiology of aortic conditions. [2]
The ELN gene encodes elastin, a vital component of elastic fibers found abundantly in the arterial wall, providing the aorta with its characteristic elasticity and resilience. Variants like rs6974735, rs6943980, and rs7795735, located in or near TMEM270 and ELN, could affect elastin synthesis, assembly, or degradation, thereby influencing aortic wall integrity and its capacity to withstand hemodynamic forces. Alterations in elastin are directly implicated in conditions ranging from aortic root dilation to aneurysm formation. Similarly, the CAST gene, encoding calpastatin, an inhibitor of calpain proteases, is crucial for regulating cellular processes like cell migration, proliferation, and extracellular matrix turnover within the vasculature. Variants such as rs55745974, rs4077816, and rs764443335 may impact calpain activity, potentially leading to dysregulated vascular remodeling that could contribute to aortic stiffening or aneurysm progression. [2]
Key transcriptional regulators also significantly impact aortic health. HDAC9 (Histone Deacetylase 9) is involved in chromatin remodeling and gene expression, influencing the phenotype of vascular smooth muscle cells (VSMCs) which are critical for maintaining aortic structure and function. The variant rs2107595, found in the region of HDAC9 and TWIST1, may modulate these regulatory processes, affecting VSMC contractility, proliferation, and matrix production, all of which are relevant to aortic disease. [4] Additionally, PLCE1 (Phospholipase C Epsilon 1) is an enzyme involved in signal transduction pathways that govern cell growth, differentiation, and cytoskeleton organization, essential for vascular development and repair. Variants including rs2689691, rs10882399, and rs79958663 in PLCE1 might alter these signaling cascades, influencing the cellular responses within the aortic wall to injury or stress. [5]
Other genes, such as MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4) and WWP2 (WW Domain Containing E3 Ubiquitin Protein Ligase 2), are involved in cellular stress responses and protein regulation, respectively. MAP2K4 is a component of the JNK signaling pathway, which is activated by various stressors and plays a role in inflammation and apoptosis, processes highly relevant to atherosclerosis and aortic aneurysm. Variants rs7215383 and rs7221449 could alter these stress responses, affecting the aorta's resilience. [6] WWP2 is an E3 ubiquitin ligase that targets proteins for degradation, thus regulating numerous cellular pathways including those involved in inflammation and cell growth. Variations like rs62053262 and rs77870048 may influence the stability of key proteins, impacting vascular cell function and contributing to aortic disease progression. [2]
Finally, long non-coding RNAs (lncRNAs) and pseudogenes represent another layer of genetic influence. LncRNAs such as LINC00540, LINC01808, LINC02269, and LINC00972 are known to regulate gene expression and are increasingly recognized for their roles in cardiovascular disease. Variants like rs1507721, rs7994761, rs9510086 (associated with LINC00540), rs824510, rs4456662, rs35786425 (associated with LINC01808), rs67846163 (in LINC02269), and rs1583081, rs771025673, rs2463481 (associated with LINC00972) may affect their regulatory functions, indirectly influencing the expression of genes critical for aortic health. Pseudogenes like FTH1P7 and DYNLL1P7, and the transmembrane protein TMEM270, also have associated variants that warrant further investigation into their potential, albeit less direct, roles in aortic pathology through mechanisms such as modulating iron metabolism, cellular transport, or cell signaling. [7]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs6974735 rs6943980 rs7795735 |
TMEM270 - ELN | ascending aorta diameter aortic measurement |
| rs1507721 rs7994761 rs9510086 |
LINC00540 - FTH1P7 | aortic measurement |
| rs55745974 rs4077816 rs764443335 |
CAST | aortic measurement |
| rs62053262 rs77870048 |
WWP2 | aortic measurement pulse pressure measurement ascending aorta diameter systolic blood pressure descending aorta diameter |
| rs824510 rs4456662 rs35786425 |
LINC01808 - CISD1P1 | aortic measurement |
| rs67846163 | LINC02269 | aortic measurement carotid artery thickness ascending aorta diameter diastolic blood pressure, systolic blood pressure pulse pressure measurement |
| rs2689691 rs10882399 rs79958663 |
PLCE1 | aortic measurement Abdominal Aortic Aneurysm |
| rs1583081 rs771025673 rs2463481 |
DYNLL1P7 - LINC00972 | ascending aorta diameter aortic measurement |
| rs2107595 | HDAC9 - TWIST1 | coronary artery disease Ischemic stroke pulse pressure measurement stroke systolic blood pressure |
| rs7215383 rs7221449 |
MAP2K4 - LINC00670 | aortic measurement ascending aorta diameter |
Defining Aortic Calcification
The aorta, as the body's largest artery, plays a central role in the circulatory system, and its condition is a critical indicator of cardiovascular health, particularly in the context of subclinical atherosclerosis. A precise definition of 'aortic' in this context often centers on specific pathologies such as abdominal aortic calcification (AAC), which refers to the presence of calcified lesions within the abdominal segment of the aorta ([2] ). Operationally, a calcified lesion in the aorta is identified through imaging as an area comprising at least three connected pixels with a computed tomography (CT) attenuation value exceeding 130 Hounsfield Units (HU), based on 3D connectivity criteria ([2] ). This quantifiable approach allows for a standardized assessment of arterial calcification.
Key terminology and nomenclature are essential for clear communication in the study of aortic conditions. AAC is the widely used abbreviation for abdominal aortic calcification, while MDCT stands for multidetector Computed Tomography, the advanced imaging technique employed for its detection and quantification ([2] ). The scoring of calcification, including AAC, often adapts methodologies from the original Agatston Score, which was initially developed for electron beam CT to assess coronary artery calcification, but has been modified for use with MDCT protocols ([2] ). Beyond calcification, "aortic root dimension" is another important term, representing a specific echocardiographic measurement of the aorta's origin, recognized for its moderate to high heritability ([1] ).
Classification of Aortic Conditions
Aortic conditions, particularly abdominal aortic calcification, are systematically classified within the broader framework of subclinical atherosclerosis (SCA), which encompasses a range of early cardiovascular disease markers. AAC is categorized as one of the primary SCA phenotypes, evaluated alongside other measures such as coronary artery calcification (CAC), carotid artery intimal-medial thickness (IMT), and ankle-brachial index (ABI) ([2] ). This classification system acknowledges the potential for distinct genetic and pathogenic pathways of atherosclerosis across different vascular beds, including the aorta, coronary arteries, and carotid arteries, allowing for targeted research into their unique determinants ([2] ). The study of these individual yet interconnected measures provides a comprehensive view of an individual's systemic atherosclerotic burden.
From a nosological perspective, AAC serves as an important intermediate phenotype in the progression from conventional cardiovascular risk factors to overt clinical cardiovascular disease. Its detection signifies an early stage of arterial pathology, characterized by stiffening and plaque formation, prior to the manifestation of symptomatic disease ([8] ). The inclusion of AAC within a panel of SCA measures reflects a dimensional approach to cardiovascular risk assessment, where the extent of calcification is quantitatively assessed and correlated with future vascular morbidity and mortality, providing a more nuanced understanding than a simple binary classification of disease presence ([8] ).
Measurement and Diagnostic Criteria for Aortic Health
The measurement and diagnostic criteria for evaluating aortic health, especially AAC, are meticulously standardized to ensure reliability and clinical relevance. Measurements of AAC are routinely performed on dedicated offline workstations by trained technicians, adhering to standardized protocols for image acquisition and interpretation ([2] ). The quantification of AAC involves a specific algorithm: the area of a calcified lesion is multiplied by a weighted CT attenuation score, which is determined by the maximal Hounsfield Units within the lesion, a method adapted from the established Agatston Score ([2] ). This methodology yields a robust, quantitative score that reflects the burden of aortic calcification.
For research and genetic association studies, AAC phenotypes undergo rigorous adjustment for various covariates to mitigate confounding influences. These adjustments include age- and sex-specific factors, as well as multivariable adjustments for clinical characteristics such as smoking status, diabetes, hypertension, total cholesterol/HDL ratio, and log-transformed triglyceride levels ([2] ). Specifically, systolic blood pressure and the use of anti-hypertensive treatment are crucial covariates, with treated blood pressure values often imputed to estimate untreated levels ([2] ). The clinical significance of these measurements is substantial, as abdominal aortic calcific deposits are recognized as a strong independent predictor of future vascular morbidity and mortality ([8] ).
Subclinical Aortic Atherosclerosis and Imaging Markers
Aortic health can be assessed through objective measures of subclinical atherosclerosis, which often presents without overt clinical symptoms. A key indicator is Abdominal Aortic Calcium (AAC), quantifiable using Multidetector Computed Tomography (MDCT). [2] This imaging technique provides a detailed assessment of calcium deposits within the abdominal aorta, serving as a direct measure of arterial calcification. The presence and extent of AAC are significant, as such subclinical atherosclerosis measures predict future cardiovascular disease risks independently of traditional risk factors. [2] Adjustments for covariates like systolic blood pressure and anti-hypertensive treatment are often applied during analysis to refine the diagnostic value of AAC measurements. [2]
Echocardiographic Assessment of Aortic Root Dimensions
The dimensions of the aortic root are critical indicators of aortic health and can be assessed non-invasively via echocardiography (Echo). [1] Aortic root diameter (AOR) is a specific echocardiographic trait that is often evaluated, with measurements sometimes averaged across multiple examinations to provide a more stable phenotypic characterization over time. [1] This approach can help mitigate regression dilution bias, although the use of different equipment and examinations spanning long periods may introduce variability. [1] The heritability of aortic root dimension has been estimated at 52%, underscoring a significant genetic component in its determination. [1]
Genetic and Environmental Influences on Aortic Phenotypes
Aortic phenotypes exhibit considerable variability influenced by both genetic predispositions and environmental factors. Genetic association studies evaluate phenotypes using sex-specific age-adjusted and multivariable-adjusted residuals to account for demographic and clinical confounders. [2] For instance, single nucleotide polymorphisms (SNPs) in or near genes such as fibroblast growth factor (FGF1) have been associated with AAC, highlighting specific genetic contributions to aortic calcification. [2] However, the generalizability of these findings can be influenced by population characteristics, as studies primarily involving individuals of European descent may not fully reflect genetic effects in other ethnicities. [1] Furthermore, environmental factors can modulate genetic effects, suggesting that gene-environment interactions may play a role in the expression of aortic traits. [1]
Causes
The development and progression of aortic conditions, such as alterations in aortic root dimension or the accumulation of abdominal aortic calcification, are influenced by a complex interplay of genetic predispositions, environmental exposures, and physiological changes over time. Research indicates a significant heritable component to these aortic traits, alongside the recognized impact of various lifestyle factors and comorbidities.
Genetic Predisposition
Genetic factors play a substantial role in determining an individual's susceptibility to aortic conditions. Studies have demonstrated a high heritability for traits like aortic root dimension, estimated at 52%, indicating a strong genetic influence. [1] Genome-wide association studies (GWAS) have identified specific single nucleotide polymorphisms (SNPs) associated with these traits; for instance, rs10488825 and rs10513272 have been linked to aortic root diameter, while rs10488813, rs35243054, and rs29573469 are associated with abdominal aortic calcification. [2] These findings highlight that variations in an individual's genetic code contribute significantly to inter-individual differences in aortic health.
Beyond specific SNPs, a broader polygenic risk is implied by the heritability of subclinical atherosclerosis measures, which include aortic calcification, suggesting that multiple genetic variants, each with a modest effect, collectively contribute to risk. [2] While candidate gene studies for cardiovascular disease have yielded inconsistent results, overviews suggest modest associations for variants in genes such as APOE and ACE with subclinical disease, which can impact the aorta. [2]
Environmental and Lifestyle Influences
Environmental and lifestyle factors are critical determinants of aortic health, impacting both aortic root dimension and the development of calcification. Key factors frequently adjusted for in studies include age, sex, body mass index, heart rate, and various indicators of cardiovascular risk. [2] Lifestyle choices such as smoking, and dietary components contributing to high total cholesterol/HDL ratio, are recognized as significant contributors to adverse aortic changes. [2] These factors contribute to systemic inflammation, endothelial dysfunction, and lipid accumulation, pathways that can directly lead to structural alterations and calcification within the aorta.
Furthermore, the presence and management of metabolic conditions profoundly influence aortic health. Diabetes and hypertension are consistently identified as major risk factors, contributing to the progression of conditions like abdominal aortic calcification. [2] Elevated systolic blood pressure, whether treated or untreated, is a direct mechanical stressor on the aortic wall, promoting remodeling and calcification over time. [2] These environmental and lifestyle elements interact with an individual's genetic makeup to modulate the overall risk profile for aortic disease.
Gene-Environment Interactions
The manifestation of aortic conditions is not solely determined by genetic or environmental factors in isolation, but often arises from complex gene-environment interactions. Genetic variants can exert their influence on aortic phenotypes in a context-specific manner, meaning their effects are modulated by various environmental exposures. [1] For example, while not directly studied for aortic traits in the provided research, the associations of genes like ACE and AGTR2 with left ventricular mass have been shown to vary based on dietary salt intake, illustrating how genetic predispositions can be activated or mitigated by specific environmental triggers. [1]
This interplay suggests that individuals with certain genetic susceptibilities may be particularly vulnerable to specific environmental stressors, leading to a higher risk of aortic pathology. Conversely, favorable environmental conditions or lifestyle interventions could potentially counteract genetic predispositions. Although direct investigations into gene-environment interactions for aortic conditions were not undertaken in the presented studies, the principle remains a crucial aspect of understanding disease etiology. [1]
Age and Comorbidity Factors
Age is an undeniable and pervasive contributor to changes in aortic structure and function. It is consistently accounted for as a significant covariate in studies analyzing aortic dimensions and calcification, indicating its independent role in the aging process of the aorta. [2] The averaging of echocardiographic traits across multiple examinations spanning decades, while useful for characterizing phenotypes over time, also highlights the potential for age-dependent gene effects to be masked, suggesting that genetic influences may vary across different life stages. [1]
Beyond chronological age, various comorbidities significantly exacerbate aortic pathology. Conditions such as diabetes, hypertension, and dyslipidemia (indicated by the total cholesterol/HDL ratio) are well-established risk factors that contribute to the development of subclinical atherosclerosis, including abdominal aortic calcification. [2] The use of medications, particularly anti-hypertensive treatments, also plays a role, as these interventions aim to mitigate the impact of high blood pressure on vascular health, including the aorta. [2] These factors collectively contribute to the degenerative processes that affect the aorta over an individual's lifespan.
Metabolic Regulation and Lipid Dynamics in Arterial Health
Subclinical atherosclerosis in major arterial territories is profoundly influenced by systemic metabolic factors and lipid dynamics. Conditions such as diabetes represent a significant metabolic perturbation that impacts arterial health, contributing to changes within the arterial wall. Lipid profiles, including the balance of total cholesterol to high-density lipoprotein (HDL) cholesterol and levels of triglycerides, are crucial in the context of arterial function and the accumulation of atherosclerotic plaques. Furthermore, body mass index (BMI) contributes to the overall metabolic milieu, playing a role in the integrity of arterial tissues. [2]
Hemodynamic Stress and Lifestyle Contributions to Arterial Condition
Hemodynamic forces and lifestyle choices play a critical role in the pathophysiology of atherosclerosis within major arteries. Hypertension, characterized by elevated treatment-adjusted systolic blood pressure, imposes significant mechanical stress on arterial walls, influencing their structure and function over time. Smoking, identified as a key lifestyle factor, also contributes to adverse conditions that promote subclinical arterial changes and compromise vascular health. These factors collectively contribute to the progression of arterial disease by disrupting normal physiological processes. [2]
Demographic and Hormonal Modulators of Arterial Biology
The susceptibility to and progression of atherosclerosis in major arterial territories are modulated by demographic and hormonal factors. Advancing age is a fundamental determinant of arterial remodeling and changes, with cumulative exposure to various risk factors contributing to arterial stiffening and plaque development. Sex-specific differences are noted in arterial health, and in women, specific hormonal contexts such as menopausal status and the use of hormone therapy are recognized as influential factors impacting the arterial system. [2]
Structural and Functional Indicators of Arterial Integrity
The structural and functional status of major arterial territories can be quantitatively assessed through specific clinical indicators. Carotid artery intima-media thickness (IMT), measured at the bulb and along the common carotid artery, provides direct insights into the arterial wall's morphological changes associated with subclinical atherosclerosis. The ankle-brachial index (ABI) serves as a functional marker, reflecting the health and patency of peripheral arteries and, by extension, systemic arterial conditions relevant to overall arterial integrity. [2]
Regulation of Vascular Smooth Muscle Function
The dynamic regulation of vascular smooth muscle cell function is critical for maintaining aortic tone and systemic blood pressure. Angiotensin II, a potent vasoconstrictor, influences this by increasing the expression of phosphodiesterase 5A (PDE5A) in vascular smooth muscle cells, thereby antagonizing cGMP signaling pathways that typically promote vasodilation. [9] This interaction highlights a key feedback loop where hormonal signals modulate intracellular cascades to control vascular contractility. Furthermore, the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, found in human endothelia, is crucial for the mechanical properties and cAMP-dependent chloride transport of aortic smooth muscle cells. [10] Its disruption can alter the physiological responses of the aorta, impacting its elasticity and function.
Lipid Metabolism and Arterial Health
Lipid metabolism pathways are central to aortic health, with dysregulation contributing to atherosclerosis and subsequent aortic stiffness. The HMGCR gene, which encodes 3-hydroxy-3-methylglutaryl-CoA reductase, is a rate-limiting enzyme in the mevalonate pathway responsible for cholesterol biosynthesis. [11] Common genetic variants (SNPs) within HMGCR have been shown to influence LDL-cholesterol levels by affecting the alternative splicing of exon 13, demonstrating a direct link between gene regulation and metabolic flux. [12] Alternative splicing is a key post-transcriptional regulatory mechanism that generates diverse protein isoforms, such as those derived from APOB mRNA, which can impact lipid transport and deposition in arterial walls. [13] These mechanisms collectively dictate systemic lipid profiles, with direct implications for the development of subclinical atherosclerosis in major arterial territories, including the aorta. [5]
Cellular Migration and Structural Integrity
Maintaining the structural integrity of the aorta involves intricate regulatory mechanisms governing cell behavior, including migration. The neuronal chemorepellent Slit2 acts as a crucial regulator in the vasculature by inhibiting the migration of vascular smooth muscle cells through the suppression of small GTPase Rac1 activation. [14] This signaling pathway is vital for preventing abnormal cell accumulation and remodeling within the aortic wall, which can contribute to vascular disease progression. Additionally, heat shock proteins, such as HSP90, are involved in cellular stress responses and protein quality control, with their expression and phosphorylation patterns potentially influencing the structural resilience of the aorta. [15] These integrated cellular mechanisms are essential for the aorta's ability to withstand hemodynamic stresses and maintain its architectural stability.
Metabolic Contributors to Aortic Disease
Beyond lipids, other metabolic pathways significantly contribute to aortic disease risk, notably those involving uric acid. Hyperuricemia, characterized by elevated serum uric acid levels, is an established risk factor for cardiovascular disease, metabolic syndrome, and arterial hypertension, conditions that can directly impact aortic health. [16] The GLUT9 gene (SLC2A9), which encodes a facilitative glucose transporter-like protein, plays a pivotal role in regulating serum uric acid concentrations and urate excretion. [17] Alternative splicing of GLUT9 transcripts can alter the protein's trafficking and functional properties, thereby influencing its capacity for urate transport. [18] This highlights how genetic variants and regulatory mechanisms within metabolic pathways can exert systemic effects that predispose individuals to aortic pathologies.
Diagnostic and Prognostic Utility of Aortic Measures
Aortic health, particularly the presence and extent of calcification within the abdominal aorta, holds significant diagnostic and prognostic value in cardiovascular medicine. Abdominal aortic calcific deposits (AAC) serve as an important predictor of future vascular morbidity and mortality. [8] The quantification of AAC, often performed using multidetector computed tomography (MDCT), provides a direct measure of subclinical atherosclerosis, allowing clinicians to identify individuals at elevated risk before the manifestation of overt cardiovascular disease. [2] Similarly, the aortic root dimension, an echocardiographic parameter, is characterized by moderate to high heritability, indicating a genetic predisposition that influences aortic structural integrity and potentially its susceptibility to pathology. [1] These measures contribute to a comprehensive assessment of cardiovascular risk, guiding clinical decisions and patient management strategies.
Risk Stratification and Personalized Management Approaches
The assessment of aortic calcification plays a crucial role in risk stratification, enabling the identification of high-risk individuals who may benefit from targeted preventive strategies or more intensive management. Genetic insights, such as the association of the FGF1 gene with AAC, offer avenues for personalized medicine by potentially identifying individuals with a genetic predisposition to accelerated aortic calcification. [2] Beyond genetics, traditional cardiovascular risk factors like hypertension, smoking, diabetes, and dyslipidemia are consistently adjusted for in analyses of subclinical atherosclerosis measures, underscoring their critical role in risk assessment and highlighting areas for clinical intervention. [2] Integrating these genetic and phenotypic markers of aortic health with conventional risk factors allows for a more nuanced understanding of an individual's cardiovascular risk profile, informing tailored treatment selection and long-term monitoring.
Aortic Health, Systemic Atherosclerosis, and Genetic Associations
Aortic pathologies, particularly calcification, are often intertwined with broader systemic atherosclerotic processes and shared genetic influences. Abdominal aortic calcification is a key indicator of subclinical atherosclerosis across multiple arterial territories, often co-occurring with coronary artery calcification (CAC) and carotid artery intima-media thickness (IMT). [2] Genome-wide association studies have identified specific single nucleotide polymorphisms (SNPs) significantly associated with AAC, suggesting common genetic pathways underlying arterial calcification throughout the vascular system. [2] Understanding these overlapping phenotypes and their genetic determinants can inform comprehensive management of patients with systemic cardiovascular disease, recognizing the aorta as a sentinel organ reflecting overall vascular health and predisposition to complications.
References
[1] Vasan RS, et al. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Medical Genetics, vol. 8, no. Suppl 1, 2007, p. S3.
[2] O'Donnell CJ, et al. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Medical Genetics, vol. 8, no. Suppl 1, 2007, p. S4.
[3] Benjamin, Emelia J., et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Medical Genetics, vol. 8, no. Suppl 1, 2007, p. S1.
[4] Willer, C. J., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40(2):161–169.
[5] Kathiresan, S., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40(2):189–197.
[6] Aulchenko, Y. S., et al. "Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts." Nat Genet, vol. 41, no. 1, 2009, pp. 47-55.
[7] McArdle, P. F., et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in Old Order Amish. Arthritis Rheum. 2008;58(9):2874–2881.
[8] Wilson PW, et al. "Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality." Circulation, vol. 103, no. 11, 2001, pp. 1529-1534.
[9] Kim, D., Aizawa, T., Wei, H., Pi, X., Rybalkin, S. D., Berk, B. C., & Yan, C. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling. J Mol Cell Cardiol. 2005;38(1):175–184.
[10] Robert, R., Norez, C., & Becq, F. Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl-transport of mouse aortic smooth muscle cells. J Physiol (Lond). 2005;568(Pt 2):483–495.
[11] Goldstein, J. L., & Brown, M. S. Regulation of the mevalonate pathway. Nature. 1990;343(6256):425–430.
[12] Burkhardt, R., et al. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arterioscler Thromb Vasc Biol. 2008;28(12):2071-2076.
[13] Khoo, B., Roca, X., Chew, S. L., & Krainer, A. R. Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB. BMC Mol Biol. 2007;8:3.
[14] Liu, D., Hou, J., Hu, X., Wang, X., Xiao, Y., Mou, Y., & De, L. H. Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation. Circ Res. 2006;98(4):480–489.
[15] Ginsberg, J., Labedz, T., & Brindley, D. N. Phosphorylation of Heat Shock Protein-90 by TSH in FRTL-5 Thyroid Cells. Thyroid. 2006;16(8):737-742.
[16] Hayden, M. R., & Tyagi, S. C. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond). 2004;1(1):10.
[17] Li, S., et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007;3(11):e194.
[18] Augustin, R., Carayannopoulos, M. O., Dowd, L. O., Phay, J. E., Moley, J. F., & Moley, K. H. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem. 2004;279(16):16229–16236.